These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19768705

  • 1. Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.
    Clifton JG, Huang F, Kovac S, Yang X, Hixson DC, Josic D.
    Electrophoresis; 2009 Oct; 30(20):3636-46. PubMed ID: 19768705
    [Abstract] [Full Text] [Related]

  • 2. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.
    Metzner HJ, Hermentin P, Cuesta-Linker T, Langner S, Müller HG, Friedebold J.
    Haemophilia; 1998 Oct; 4 Suppl 3():25-32. PubMed ID: 10028315
    [Abstract] [Full Text] [Related]

  • 3. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
    Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS, Wilate PK Study Investigators.
    Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
    [Abstract] [Full Text] [Related]

  • 4. Optimizing therapy with factor VIII/von Willebrand factor concentrates in von Willebrand disease.
    Federici AB, Mannucci PM.
    Haemophilia; 1998 Aug; 4 Suppl 3():7-10. PubMed ID: 10028312
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 6. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
    Favaloro EJ, Bukuya M, Martinelli T, Tzouroutis J, Duncan E, Welldon K, Collecutt M, Aumann H, Thom J, Gilmore G.
    Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
    [Abstract] [Full Text] [Related]

  • 7. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S, Carlson M, Hillarp A.
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [Abstract] [Full Text] [Related]

  • 8. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial.
    Mannucci PM, Tenconi PM, Castaman G, Rodeghiero F.
    Blood; 1992 Jun 15; 79(12):3130-7. PubMed ID: 1596562
    [Abstract] [Full Text] [Related]

  • 9. Characterization of von Willebrand factor in factor VIII concentrates.
    Fricke WA, Yu MY.
    Am J Hematol; 1989 May 15; 31(1):41-5. PubMed ID: 2495715
    [Abstract] [Full Text] [Related]

  • 10. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.
    Blood Coagul Fibrinolysis; 2009 Mar 15; 20(2):89-100. PubMed ID: 19786936
    [Abstract] [Full Text] [Related]

  • 11. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 15; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 12. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR, Rigsby P, Barrowcliffe TW.
    Thromb Haemost; 2001 Apr 15; 85(4):634-8. PubMed ID: 11341497
    [Abstract] [Full Text] [Related]

  • 13. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
    Lin Y, Yang X, Chevrier MC, Craven S, Barrowcliffe TW, Lemieux R, Ofosu FA.
    Haemophilia; 2004 Sep 15; 10(5):459-69. PubMed ID: 15357771
    [Abstract] [Full Text] [Related]

  • 14. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB.
    Blood Coagul Fibrinolysis; 2005 Apr 15; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [Abstract] [Full Text] [Related]

  • 15. Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach.
    Basilico F, Nardini I, Mori F, Brambilla E, Benazzi L, De Palma A, Rosti E, Farina C, Mauri P.
    J Pharm Biomed Anal; 2010 Sep 21; 53(1):50-7. PubMed ID: 20399057
    [Abstract] [Full Text] [Related]

  • 16. Effect of virucidal heat treatment on proteins in human factor VIII concentrates.
    Thomas KB, McGrath KM, Taylor M, Young IF, Herrington RW, Schiff P.
    Transfusion; 1988 Sep 21; 28(1):8-13. PubMed ID: 3124306
    [Abstract] [Full Text] [Related]

  • 17. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB, Barrowcliffe TW.
    Thromb Haemost; 1992 Aug 03; 68(2):155-9. PubMed ID: 1412160
    [Abstract] [Full Text] [Related]

  • 18. von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients.
    Kallas A, Talpsep T.
    Haemophilia; 2001 Jul 03; 7(4):375-80. PubMed ID: 11442642
    [Abstract] [Full Text] [Related]

  • 19. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I, Farrugia A, Tran E, Anastasius V, Charnock A.
    Biologicals; 1998 Jun 03; 26(2):155-66. PubMed ID: 9811523
    [Abstract] [Full Text] [Related]

  • 20. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC.
    J Thromb Thrombolysis; 2008 Oct 03; 26(2):150-3. PubMed ID: 17786534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.